|
[1]OZAKI Y,KONTANI K,TERAMOTO K,et al.Involvement o90K/Mac-2 binding protein in cancer metastases by increased cellular adhesiveness in lung cancer[J].Oncol Rep,2004,12(5):1071-1077.
|
|
[2]CHE UNG KJ,TILLEMAN K,DEFORCE D,et al.Usefulness of a novel serum proteome-derived index FI-PRO(fibrosis-protein)in the prediction of fibrosis in chronic hepatitis C[J].Eur J Gastroentero Hepatol,2011,23(8):701-710.
|
|
[3]ITO K,KUNO A,IKEHARA Y,et al.LecT-hepa,a glycomarker derived from multiple lectins,as a predictor of liver fibrosis in chronic hepatitis C patients[J].Hepatology,2012,56(4):1448-1456.
|
|
[4]KUNO A,IKEHARA Y,TANAKA Y,et al.A serum'sweetdoughnut'protein facilitates fibrosis evaluation and therapy assessment inpatients with viral hepatitis[J].Sci Rep,2013,3:1065.
|
|
[5]TOSHIMA T,SHIRABE K,IKEGAMI T,et al.A novel serum marker,glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein(WFA+-M2BP),for assessing liver fibrosis[J].J Gastroenterol,2015,50(1):76-84.
|
|
[6]KUNO A,UCHIYAMA N,KOSEKI-KUNO S,et al.Evanescent-field luorescence-assistedlectin microarray:a new strategy for glycanprofiling[J].Nat Methods,2005,2(11):851-856.
|
|
[7]URA K,FURUSYO N,OGAWA E,et al.Serum WFA(+)-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C[J].Aliment Pharmacol Ther,2015,43(1):114-124.
|
|
[8]THEIN HH,YI Q,DORE GJ,et al.Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection:a meta-analysis and meta-regression[J].Hepatology,2008,48(2):418-431.
|
|
[9]ISHIDA H,SUETSUGU A,NAKAMURA M,et al.Change in serum levels of new hepatic fibrosis marker“Mac-2 binding protein glycosylation isomer(M2BPGi)”in patients with chronic hepatitis C during the treatment of pegylated interferon and ribavirin[J].Rinsho Byori,2015,63(8):901-906.
|
|
[10]MIYAKI E,IMAMURA M,HIRAGA N,et al.Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients[J].Hepatol Res,2016,46(8):758-764.
|
|
[11]URA K,FURUSYO N,OGAWA E,et al.Serum WFA+-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C[J].Aliment Pharmacol Ther,2016,43(1):114-124.
|
|
[12]KAMADA Y,FUJII H,FUJII H,et al.Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steato hepatitis[J].Proteomics Clin Appl,2013,7(9-10):648-656.
|
|
[13]ABE M,MIYAKE T,KUNO A,et al.Association between Wisteria floribunda agglutinin-positive Mac-2binding protein and the fibrosis stage of non-alcoholic fatty liverdisease[J].J Gastroenterol,2015,50(7):776-784.
|
|
[14]DU D,ZHU X,KUNO A,et al.Comparison of LecT-Hepa and FibroS can for assessment of liver fibrosis in hepatitis B virus infected patientswith different ALT levels[J].Clin Chim Acta,2012,413(21-22):1796-1799.
|
|
[15] TOSHIMA T,SHIRABE K,IKEGAMI T,et al.A novel serum marker,glycosylated Wisteria floribundaagglutinin-positive Mac-2 binding protein(WFA+-M2BP),for assessing liver fibrosis[J].J Gastroenterol,2015,50(1):76-84.
|
|
[16]ICHIKAWA Y,JOSHITA S,UMEMURA T,et al.Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection[J].Hepatol Res,2016.[Epub ahead of print]
|
|
[17]NISHIKAWA H,ENOMOTO H,IWATA Y,et al.Serum wisteria floribunda agglutinin-positive mac-2-binding protein for patients with chronic hepatitis B and C:a comparative study[J].JViral Hepat,2016,23(12):977-984.
|
|
[18]UMEMURA T,JOSHITA S,SEKIGUCHI T,et al.Serum wisteria floribunda agglutinin-positive mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis[J].Am J Gastroenterol,2015,110(6):857-864.
|
|
[19]NISHIKAWA H,ENOMOTO H,IWATA Y,et al.Impact of serum Wisteria Floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis[J].Hepatol Res,2016,46(6):575-583.
|
|
[20]YAMASAKI K,TATEYAMA M,ABIRU S,et al.Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2binding protein predict thedevelopment of hepatocellular carcinoma in hepatitis C patients[J].Hepatology,2014,60(5):1563-1570.
|
|
[21]FUJIYOSHI M,KUNO A,GOTOH M,et al.Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma[J].J Gastroenterol,2015,50(11):1134-1144.
|
|
[22]YAMASAKI K,TATEYAMA M,ABIRU S,et al.Elevated serum levels of WFA-M2BP predict the development of hepatocellular carcinoma in hepatitis C patients[J].Hepatology,2014,60(5):1563-1570.
|
|
[23]HANAI T,SHIRAKI M,OHNISHI S,et al.Impact of serum glycosylated Wisteria floribunda agglutininpositive Mac-2 binding protein levels on liver functionalreserves and mortality in patients with liver cirrhosis[J].Hepatol Res,2015,45(11):1083-1090.
|
|
[24]CASSINOTTOC,LAPUYADE B,MOURIES A,et al.Non-invasive assessment of liver fibrosis with impulse elastography:comparison of Supersonic Shear Imaging with ARFI and FibroS can?[J].JHepatol,2014,61(3):550-557.
|
|
[25]ASRANI SK.Incorporation of noninvasive measures of liver fibrosis into clinical practice:diagnosis and prognosis[J].Clin Gastroenterol Hepatol,2015,13(12):2190-2204.
|
DownLoad: